All peptides used in this study for Parkinson’s disease were synthesized by LifeTein. The α-synuclein is an indication in the pathogenesis of Parkinson’s disease. It was found that a molecular mimicry mechanism between HSV1 and human α-synuclein could trigger PD.
LifeTein Peptides & Parkinson’s Disease
Journal of Neuroimmunology, doi:10.1016/j.jneuroim.2016.01.007 Humoral cross reactivity between α-synuclein and herpes simplex − 1 epitope in Parkinson’s disease, a triggering role in the disease?